Correction: Effectiveness of PARP Inhibitor Maintenance Therapy in Ovarian Cancer by BRCA1/2 and a Scar-Based HRD Signature in Real-World Practice
更正：真实世界实践中基于BRCA1/2和瘢痕组织HRD特征的卵巢癌患者接受PARP抑制剂维持治疗的有效性
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-2196
Richardson, Debra L; Quintanilha, Julia C F; Danziger, Natalie; Li, Gerald; Sokol, Ethan; Schrock, Alexa B; Ebot, Ericka; Bhardwaj, Neeru; Norris, Tanesha; Afghahi, Anosheh; Frachioni, Anthony; Washington, Christina; Dockery, Lauren; Elvin, Julia; Graf, Ryon P; Moore, Kathleen N
